BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 288 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $34,777,000 | +26.7% | 238,670 | +3.1% | 1.38% | +51.5% |
| Q1 2022 | $27,453,000 | -33.6% | 231,537 | -22.8% | 0.91% | -26.3% |
| Q4 2021 | $41,339,000 | +248.0% | 299,972 | +250.8% | 1.24% | +237.3% |
| Q3 2021 | $11,880,000 | -61.4% | 85,520 | -73.1% | 0.37% | -60.0% |
| Q2 2021 | $30,808,000 | +39.9% | 317,348 | -1.5% | 0.92% | +29.5% |
| Q1 2021 | $22,015,000 | +22.9% | 322,087 | +54.1% | 0.71% | +19.4% |
| Q4 2020 | $17,909,000 | +34.0% | 208,946 | +1.6% | 0.59% | +2.2% |
| Q3 2020 | $13,367,000 | -19.2% | 205,620 | -9.1% | 0.58% | -21.8% |
| Q2 2020 | $16,543,000 | – | 226,282 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $108,659,000 | 54.35% |
| Knoll Capital Management, LLC | 749,815 | $38,593,000 | 29.33% |
| VHCP Management II, LLC | 1,138,075 | $58,577,000 | 17.14% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,021,392 | $52,571,000 | 11.19% |
| Aisling Capital Management LP | 274,513 | $14,129,000 | 10.76% |
| Foresite Capital Management IV, LLC | 518,560 | $26,690,000 | 9.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 844,266 | $43,454,000 | 5.81% |
| ACUTA CAPITAL PARTNERS, LLC | 206,000 | $10,603,000 | 5.04% |
| ARS Investment Partners, LLC | 464,127 | $23,889,000 | 4.32% |
| Cormorant Asset Management, LP | 1,100,000 | $56,617,000 | 3.83% |